MAR 20 update

Market news and events impacting portfolio positions

Mar 20, 2026

∙ Paid

Biotech earnings expectations, new drug studies and application submission for approval, in addition to ticking boxes for merger deal closure, and silver in action again.

Continue reading this post for free, courtesy of Marius Čiuželis.

Or purchase a paid subscription.